Additional Metadata
Keywords ISCOM, Matrix M, Quillaja saponaria Molina, Th1/Th2, saponin, vaccine adjuvant
Persistent URL dx.doi.org/10.1586/erv.11.25, hdl.handle.net/1765/34396
Citation
Lövgren-Bengtsson, K, Morein, B, & Osterhaus, A.D.M.E. (2011). ISCOM technology-based Matrix M™ adjuvant: Success in future vaccines relies on formulation. Expert Review of Vaccines, 10(4), 401–403. doi:10.1586/erv.11.25